We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BrainStorm to Evaluate Stem Cell Treatment in Alzheimer’s Patients
BrainStorm to Evaluate Stem Cell Treatment in Alzheimer’s Patients
New York-based BrainStorm Cell Therapeutics is launching a phase 2 trial of an investigational stem cell treatment for Alzheimer’s disease, using cells derived from patients’ bone marrow.